Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04718636 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Participants
A Phase 1 study, sponsored by Celgene.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT04718636 is a Phase 1 study that has completed, run by Celgene. The registered enrollment target is 28 participants.
The verdict
NCT04718636, a Phase 1 study, has completed, sponsored by Celgene.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of CC-99677 coadministration on the pharmacokinetics (PK) of an oral contraceptive (OC).
Interventions
- DRUG Oral Contraceptive (Ortho Tri-Cyclen or its generic equivalent)
- DRUG CC-99677
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-09-30 |
| Est. Completion | 2021-08-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04718636
The ClinicalTrials.gov registry entry for NCT04718636 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Celgene, which has 308 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oral Contraceptive (Ortho Tri-Cyclen or its generic equivalent) is the first listed.
NCT04718636 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04718636 about?
NCT04718636 is a clinical study titled "A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Participants". The purpose of this study is to evaluate the effect of CC-99677 coadministration on the pharmacokinetics (PK) of an oral contraceptive (OC).
What is the current status of trial NCT04718636?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2020-09-30. Estimated completion is 2021-08-03.
What interventions are being tested in trial NCT04718636?
The interventions under investigation include: Oral Contraceptive (Ortho Tri-Cyclen or its generic equivalent) (DRUG), CC-99677 (DRUG).
Who is sponsoring clinical trial NCT04718636?
This trial is sponsored by Celgene, which has 308 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.